Treatment Strategies for Patients With Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer
To access this article, please choose from the options below
PII: S0093-7754(08)00048-1
doi:10.1053/j.seminoncol.2008.02.009
PII: S0093-7754(08)00048-1
doi:10.1053/j.seminoncol.2008.02.009